Form EFFECT Rein Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 30, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Prices $3.3 Million Private Placement to Support AI and Product Development
- Advance America Answers Consumer Demand with FlexFund Line of Credit
- MBIA Inc. Investor Conference Call to Discuss Second Quarter 2026 Financial Results Scheduled for Friday, August 7 at 8:30 A.M. Eastern Time
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
